Estrogen receptor: loss of DNA binding ability following trypsin or Ca2+ treatment.
D000818:Animals; D001665:Binding Sites; D002118:Calcium / Q000494:pharmacology*; D002417:Cattle; D002499:Centrifugation, Density Gradient; D002850:Chromatography, Gel; D003600:Cytosol / Q000378:metabolism; D004247:DNA / Q000378:metabolism*; D004958:Estradiol / Q000378:metabolism*; D005260:Female; D007531:Isoflurophate / Q000494:pharmacology; D011485:Protein Binding; D011956:Receptors, Cell Surface; D013056:Spectrophotometry, Ultraviolet; D013950:Thymus Gland; D013997:Time Factors; D014316:Tritium; D014357:Trypsin / Q000494:pharmacology*; D014361:Trypsin Inhibitors / Q000494:pharmacology; D014599:Uterus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D011956:Receptors, Cell Surface; D014361:Trypsin Inhibitors; D014316:Tritium; D007531:Isoflurophate; D004958:Estradiol; D004247:DNA; D014357:Trypsin; D002118:Calcium